View original post here: Quarterly Activities Update: Encouraging Growth for geneType Commercial Test Volume
View original post here: Quarterly Activities Update: Encouraging Growth for geneType Commercial Test Volume
Originally posted here: Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2023 Financial Results
More: Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites
Go here to see the original: Lexicon Elects Diane E. Sullivan to Board of Directors
View original post here: Chinook Therapeutics Announces First Patient Enrolled in Pivotal Phase 3 BEYOND Study of Zigakibart (BION-1301) for Patients with IgA Nephropathy
View post: Ambrx to Present Preliminary ARX517 First-in-Human Safety, Efficacy, and Pharmacokinetics Data at ESMO 2023
Visit link: IO Biotech Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial at University of California Davis Comprehensive Cancer Center
Continued here: T2 Biosystems to Attend Upcoming Investor Conferences
Excerpt from: RetinalGeniX Technologies Inc. Granted Patent for Patient Home Monitoring and Physician Alert System for Ocular Anatomy
Link: Adamis Pharmaceuticals to Fund ZIMHI® Clinical Study with University of Leiden Opioid Expert
Recent Comments